Intervention: Carboplatin + Pemetrexed + Bevacizumab + Atezolizumab (Arm A) versus Carboplatin + Pemetrexed + Bevacizumab (arm B).IC: chemotherapy, anti-VEGF therapy alone, and immunotherapy naive, EGFR mutant NSCLC or smoking history of < 100 cigarettes.1EP: PFS. Here, EGFR is linked to non-small cell lung carcinoma.